ATE233093T1 - Arzneimittel zur vermeidung und umkehrung der atherosklerose bei säugetieren - Google Patents

Arzneimittel zur vermeidung und umkehrung der atherosklerose bei säugetieren

Info

Publication number
ATE233093T1
ATE233093T1 AT99972104T AT99972104T ATE233093T1 AT E233093 T1 ATE233093 T1 AT E233093T1 AT 99972104 T AT99972104 T AT 99972104T AT 99972104 T AT99972104 T AT 99972104T AT E233093 T1 ATE233093 T1 AT E233093T1
Authority
AT
Austria
Prior art keywords
preventing
mammals
aliquot
mammal
medicinal products
Prior art date
Application number
AT99972104T
Other languages
English (en)
Inventor
Duncan J Stewart
Original Assignee
Vasogen Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/304,262 external-priority patent/US6264646B1/en
Application filed by Vasogen Ireland Ltd filed Critical Vasogen Ireland Ltd
Application granted granted Critical
Publication of ATE233093T1 publication Critical patent/ATE233093T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0023—Aggression treatment or altering
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
AT99972104T 1998-11-13 1999-11-15 Arzneimittel zur vermeidung und umkehrung der atherosklerose bei säugetieren ATE233093T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19023698A 1998-11-13 1998-11-13
US09/304,262 US6264646B1 (en) 1998-11-13 1999-05-06 Method for preventing and reversing atherosclerosis in mammals
PCT/CA1999/001092 WO2000029003A2 (en) 1998-11-13 1999-11-15 Method for preventing and reversing atherosclerosis in mammals

Publications (1)

Publication Number Publication Date
ATE233093T1 true ATE233093T1 (de) 2003-03-15

Family

ID=26885899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99972104T ATE233093T1 (de) 1998-11-13 1999-11-15 Arzneimittel zur vermeidung und umkehrung der atherosklerose bei säugetieren

Country Status (16)

Country Link
EP (1) EP1128837B1 (de)
JP (1) JP2002529510A (de)
CN (1) CN1230182C (de)
AT (1) ATE233093T1 (de)
AU (1) AU768300B2 (de)
BR (1) BR9915270A (de)
CA (1) CA2348599A1 (de)
CZ (1) CZ20011642A3 (de)
DE (1) DE69905602T2 (de)
DK (1) DK1128837T3 (de)
EA (1) EA003421B1 (de)
ES (1) ES2192885T3 (de)
MX (1) MXPA01004801A (de)
NO (1) NO20012311L (de)
NZ (1) NZ511467A (de)
WO (1) WO2000029003A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2271190A1 (en) 1999-05-06 2000-11-06 Vasogen Ireland Limited Improved method for treating mammals with modified mammalian blood
US7125897B1 (en) 1999-09-24 2006-10-24 Vasogen Ireland Limited Combined therapies for atherosclerosis treatment
CA2309417A1 (en) 2000-05-25 2001-11-25 Anthony E. Bolton Apoptotic entities for use in treatment of endothelium dysfunction disorders
WO2005097145A1 (en) * 2004-04-12 2005-10-20 Vasogen Ireland Limited Myocarditis treatment
WO2008000067A1 (en) * 2006-06-26 2008-01-03 Vasogen Ireland Limited Treatment of mild chronic heart failure in human patients
RU2475275C1 (ru) * 2011-08-08 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения облитерирующего атеросклероза артерий нижних конечностей
RU2475276C1 (ru) * 2011-08-09 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения облитерирующего атеросклероза артерий нижних конечностей
RU2475274C1 (ru) * 2011-08-09 2013-02-20 Государственное образовательное учреждение высшего профессионального образования "Самарский государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации Способ лечения атеросклероза артерий нижних конечностей

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD249143A3 (de) * 1985-03-20 1987-09-02 Ilmenau Tech Hochschule Vorrichtung zur physiologisch-therapeutisch wirksamen optischen bestrahlung koerpereigenen venenblutes
US5980954A (en) * 1992-02-07 1999-11-09 Vasogen Ireland Limited Treatment of autoimmune diseases
WO1993015778A1 (en) * 1992-02-07 1993-08-19 Anthony Ernest Bolton Method of inhibiting the aggregation of blood platelets

Also Published As

Publication number Publication date
BR9915270A (pt) 2003-12-30
CA2348599A1 (en) 2000-05-25
ES2192885T3 (es) 2003-10-16
CN1330549A (zh) 2002-01-09
DE69905602T2 (de) 2003-10-09
EP1128837B1 (de) 2003-02-26
DE69905602D1 (de) 2003-04-03
DK1128837T3 (da) 2003-06-16
EA200100543A1 (ru) 2001-10-22
EA003421B1 (ru) 2003-04-24
AU1145000A (en) 2000-06-05
NO20012311D0 (no) 2001-05-10
CZ20011642A3 (cs) 2002-06-12
CN1230182C (zh) 2005-12-07
EP1128837A2 (de) 2001-09-05
WO2000029003A2 (en) 2000-05-25
NZ511467A (en) 2002-12-20
NO20012311L (no) 2001-07-02
MXPA01004801A (es) 2002-09-18
JP2002529510A (ja) 2002-09-10
WO2000029003A3 (en) 2000-08-31
AU768300B2 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
GB9807639D0 (en) Anti-inflammatory agents
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
ES2192642T3 (es) Producto para el teñido oxidante de fibras de queratina..
MY138883A (en) Use of asiatic acid for treatment of cencer
EA199800667A1 (ru) Новые фенантридины
NO911360D0 (no) Forvrengnings-linearisator for mikroboelge-effekt-forsterkere.
ATE288264T1 (de) Kombinationspräparate zur behandlung von erkrankungen, die mit angiogenese verbunden sind
AU6838590A (en) Cyclopropyl derivative lipoxygenase inhibitors
ATE257152T1 (de) N-benzyl-3-indenylaceamidderivative zur behandlung von neoplasia
DE69905602D1 (de) Arzneimittel zur vermeidung und umkehrung der atherosklerose bei säugetieren
CA2227711A1 (en) Thioctic acid metabolites and methods of use thereof
ES2167678T3 (es) Tratamiento y profilaxis de la pancreatitis.
CA2293808A1 (en) Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases
ATE131725T1 (de) Formulierungen zur behandlung der vaginalen trockenheit
AU4779599A (en) Methods of inhibiting (helicobacter pylori)
MXPA02004699A (es) Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco.
AU4643501A (en) Use of vascular endothelial growth factor, placenta growth factor or both for preventing or treating ischemic diseases or stroke
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya
WO2001022976A3 (en) Combination of a statin and ex-vivo treated blood for treating artheroclerosis
WO2000058506A3 (en) Susceptibility to psoriasis
GB9723824D0 (en) Cytostatic agents
DE60314123D1 (de) Selektive oxidation mit erhöhter sicherheit
UA32314A (uk) Спосіб лікування некротичного панкреатиту
UA32153A (uk) Спосіб формування трансплантату для зведення на промежину при черевно-анальних резекціях прямої кишки
MY105242A (en) Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1128837

Country of ref document: EP

REN Ceased due to non-payment of the annual fee